Apple Watch hypertension feature wins FDA nod, rollout next week, Bloomberg reports


FILE PHOTO: An Apple Watch series 11 titanium is displayed during Apple's event at the Steve Jobs Theater on its campus in Cupertino, California, U.S. September 9, 2025. REUTERS/Manuel Orbegozo/File Photo

(Reuters) -Apple will roll out a hypertension detection feature on its smartwatch next week after receiving U.S. Food and Drug Administration (FDA) clearance on Thursday, Bloomberg News reported.

Apple and the FDA did not immediately respond to Reuters' requests for comment.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

LG Elec says Microsoft and LG affiliates pursuing cooperation on data centres
Apple appoints Meta's Newstead as general counsel amid executive changes
AI's rise stirs excitement, sparks job worries
Australia's NEXTDC inks MoU with OpenAI to develop AI infrastructure in Sydney, shares jump
SentinelOne forecasts quarterly revenue below estimates, CFO to step down
Hewlett Packard forecasts weak quarterly revenue, shares fall
Microsoft to lift productivity suite prices for businesses, governments
Bank of America expands crypto access for wealth management clients
Italy launches 'in-depth' review of cryptocurrency risks
FCC approves AT&T $1 billion purchase of spectrum from US Cellular

Others Also Read